Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Libicare
- Development stage
- Unknown
- Lead developer
- Procare Health
- Administration
- Oral
01
Overview
Libicare is a multi-ingredient nutraceutical developed by Procare Health to address female sexual dysfunction (FSD) and low sexual desire. The formulation is composed of standardized botanical extracts, including *Trigonella foenum-graecum* (Fenugreek), *Tribulus terrestris*, *Turnera diffusa* (Damiana), and *Ginkgo biloba*, alongside essential minerals such as Zinc and Selenium, and B-group vitamins (B2, B3, B6). Its primary mechanism involves the modulation of free testosterone levels and the enhancement of peripheral blood flow to the genital area, thereby improving sexual arousal, desire, and overall satisfaction. Clinical evidence, including the LIBICARE study, has demonstrated its efficacy in improving sexual function scores in both premenopausal and postmenopausal women. The product is marketed as a food supplement and is available in several variants, including Libicare Meno, which includes additional ingredients like hops to manage menopausal symptoms.
- Brand names
- LibicareLibicare MenoLibicare ONE
02
Targets
NO2- (Nitrite)AR (Adrenergic receptors)
Beyond the preview
Go deeper on Libicare.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Libicare.